thyroid cancer
Veracyte Q1 Revenues up 22 Percent as Firm Beats Analyst Estimates
The company's testing revenues rose 29 percent in Q1 thanks to increased adoption of its Decipher Prostate and Afirma tests.
Veracyte Ramps up Clinical Evidence Generation, Driving Gains in Prostate and Thyroid Test Business
Premium
The company reported significant revenue growth for Q4 2022, which it attributed to its success in driving clinical test adoption.
OncoDNA, Eli Lilly Partner on Thyroid Cancer Biomarker Testing
The companies are working together to offer next-generation sequencing-based molecular testing on thyroid cancer biopsies to clinicians in Italy.
Thermo Fisher Gets FDA OK for CDx Test to Guide Use of Lilly Drug in Lung, Thyroid Cancers
The NGS-based Oncomine Dx Target Test will help ID patients with advanced RET-driven lung and thyroid cancers who may be eligible for treatment with Eli Lilly's Retevmo.
Genetron Health Adds New Assays to Pipeline While Anticipating MRD Launch, Liver Cancer Kit Trials
Premium
As it eyes new targets, the firm is poised to launch its personalized solid tumor MRD assay this year and is progressing toward approval for a liver cancer early detection IVD.
Jan 31, 2020
Dec 20, 2019
Oct 16, 2019
Aug 13, 2019